Drug-induced immune thrombocytopenia
HEALTH GUIDE REFERENCE FROM A.D.A.M
Definition
Drug-induced immune thrombocytopenia is a condition in which the use of certain drugs leads to the formation of antibodies against clot-forming cells in the blood (platelets). These antibodies can cause a low platelet count, which makes bleeding more likely.
Causes, incidence, and risk factors
If the antibodies to platelets form during pregnancy, they may pass from the mother to her unborn baby (fetus).
Review Date: 4/27/2007
Reviewed By: Rita Nanda, M.D., Department of Medicine, Section of Hematology/Oncology, University of Chicago Medical Center, Chicago, IL. Review provided by VeriMed Healthcare Network.
Reviewed By: Rita Nanda, M.D., Department of Medicine, Section of Hematology/Oncology, University of Chicago Medical Center, Chicago, IL. Review provided by VeriMed Healthcare Network.
A.D.A.M., Inc. is accredited by URAC, also known as the American Accreditation HealthCare Commission (www.urac.org). URAC's accreditation program is an independent audit to verify that A.D.A.M. follows rigorous standards of quality and accountability. A.D.A.M. is among the first to achieve this important distinction for online health information and services. Learn more about A.D.A.M.'s editorial policy, editorial process and privacy policy. A.D.A.M. is also a founding member of Hi-Ethics and subscribes to the principles of the Health on the Net Foundation (www.hon.ch).
A.D.A.M. Copyright
The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed medical professional should be consulted for diagnosis and treatment of any and all medical conditions. Call 911 for all medical emergencies. Links to other sites are provided for information only -- they do not constitute endorsements of those other sites. © 1997-2012 A.D.A.M., Inc. Any duplication or distribution of the information contained herein is strictly prohibited.
Source Doc: 1_000555
